Literature DB >> 15561996

Bigenic Cre/loxP, puDeltatk conditional genetic ablation.

You-Tzung Chen1, Regis Levasseur, Sukeshi Vaishnav, Gerard Karsenty, Allan Bradley.   

Abstract

Genetic ablation experiments are used to resolve problems regarding cell lineages and the in vivo function of certain groups of cells. We describe a two-component conditional ablation technology using a mouse carrying an X-linked puDeltatk transgene, which is only activated in cells expressing Cre. Ablation of the Cre-expressing cells can be temporally regulated by the time of ganciclovir (GCV) administration. This strategy was demonstrated using a Col2Cre transgenic line. Differentiating chondrocytes in bigenic animals could be ablated at different developmental stages resulting in disorganized growth plates and dwarfism. Macrocephaly, macroglossia and umbilical hernia were also observed in ablated 18.5 dpc embryos. Crosses between the puDeltatk selector transgenic line and existing cre lines will facilitate numerous temporally regulated tissue-specific ablation experiments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561996      PMCID: PMC534639          DOI: 10.1093/nar/gnh158

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  45 in total

1.  Genetic ablation reveals that the roof plate is essential for dorsal interneuron specification.

Authors:  K J Lee; P Dietrich; T M Jessell
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

2.  Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice.

Authors:  D A Ovchinnikov; J M Deng; G Ogunrinu; R R Behringer
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

3.  A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells.

Authors:  Y T Chen; A Bradley
Journal:  Genesis       Date:  2000-09       Impact factor: 2.487

4.  Widespread recombinase expression using FLPeR (flipper) mice.

Authors:  F W Farley; P Soriano; L S Steffen; S M Dymecki
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

5.  [Improvement of the vomeronasal organ ablation in the rat].

Authors:  N Igarashi; K Tauchi; T Imamichi; T R Saito
Journal:  Jikken Dobutsu       Date:  1988-07

6.  Normal long bone growth and development in type X collagen-null mice.

Authors:  R Rosati; G S Horan; G J Pinero; S Garofalo; D R Keene; W A Horton; E Vuorio; B de Crombrugghe; R R Behringer
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

7.  Bone embedding in pure methyl methacrylate at low temperature preserves enzyme activities.

Authors:  D Chappard; S Palle; C Alexandre; L Vico; G Riffat
Journal:  Acta Histochem       Date:  1987       Impact factor: 2.479

8.  Targeting of an inducible toxic phenotype in animal cells.

Authors:  E Borrelli; R Heyman; M Hsi; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

9.  Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone.

Authors:  S W Li; D J Prockop; H Helminen; R Fässler; T Lapveteläinen; K Kiraly; A Peltarri; J Arokoski; H Lui; M Arita
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

10.  Fibroblast growth factor receptor 3 is a negative regulator of bone growth.

Authors:  C Deng; A Wynshaw-Boris; F Zhou; A Kuo; P Leder
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

View more
  5 in total

Review 1.  Molecular neuroanatomy's "Three Gs": a primer.

Authors:  Susan M Dymecki; Jun Chul Kim
Journal:  Neuron       Date:  2007-04-05       Impact factor: 17.173

2.  Type II collagen-positive progenitors are important stem cells in controlling skeletal development and vascular formation.

Authors:  Xinhua Li; Shuting Yang; Gongsheng Yuan; Dian Jing; Ling Qin; Hu Zhao; Shuying Yang
Journal:  Bone Res       Date:  2022-06-23       Impact factor: 13.362

Review 3.  Connecting teratogen-induced congenital heart defects to neural crest cells and their effect on cardiac function.

Authors:  Ganga H Karunamuni; Pei Ma; Shi Gu; Andrew M Rollins; Michael W Jenkins; Michiko Watanabe
Journal:  Birth Defects Res C Embryo Today       Date:  2014-09-15

Review 4.  Use of transgenic animals to improve human health and animal production.

Authors:  L-M Houdebine
Journal:  Reprod Domest Anim       Date:  2005-08       Impact factor: 2.005

5.  CNS fibroblasts form a fibrotic scar in response to immune cell infiltration.

Authors:  Thomas D Arnold; Richard Daneman; Cayce E Dorrier; Dvir Aran; Ezekiel A Haenelt; Ryan N Sheehy; Kimberly K Hoi; Lucija Pintarić; Yanan Chen; Carlos O Lizama; Kelly M Cautivo; Geoffrey A Weiner; Brian Popko; Stephen P J Fancy
Journal:  Nat Neurosci       Date:  2021-02-01       Impact factor: 24.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.